NAGENiagen Bioscience, Inc.
Since it joined the list
$NAGE landed on the list 2026-03-08, down 65.2% from its 52-week high that day — now $3.84.
That's 11.5 percentage points deeper than the day it joined.
Decline from the 52-week high as it stood on 2026-03-09 (fixed anchor) → today. Split-adjusted, Alpaca. Observed history, not a forecast.
Structural break signals
NAGE qualifies for the Amber List on decline sigma.
The structural read
What price action says about NAGE.
NAGE qualifies for the Amber List on decline sigma — the recent drop measures 5.9σ over a 20-bar window. Sigma scales the move by the stock's own typical daily volatility, so a small percentage drop in a normally-quiet name can land here when the bigger players miss it on a pure-percent threshold.
Cross-confirmation: also showing 4/5 bearish time frames.
52-week range
Questions about NAGE
What people ask.
Why is NAGE on Broken Stocks?
NAGE qualifies for the Amber List on decline sigma. The recent drop measures 5.9σ over a 20-bar window — large enough that even a small percentage drop is structurally significant given the stock's typical day-to-day volatility (4.33%).
Is NAGE a falling knife?
NAGE is on Broken Stocks for time-frame continuity or decline-sigma reasons rather than headline depth, so the falling-knife label doesn't cleanly apply. The phrase usually requires a meaningful percentage drop from a fresh high. See the structural break signals above for the axis that actually triggered the listing.
Is NAGE a buy?
Broken Stocks does not issue buy or sell recommendations. The list is a rules-based technical warning system. It tracks structural decline depth and recency — not company quality, management, fundamentals, or news. Always do your own research and consult a licensed advisor.
Where is NAGE trading inside its 52-week range?
At $3.84, NAGE sits 12.4% of the way from its 52-week low ($3.56) to its 52-week high ($5.78). A reading below 25% indicates price is hugging the bottom of the range; above 75%, the top.